Tumour uptake of [18F]rucaparib was markedly higher than that of [18F]olaparib (3.16 ± 0.36%ID/g; P < 0.01) in the same PSN1 xenografts at 1 h post-injection reported previously [15]. The gene discussed is NT5C3A; the disease is neoplasm.